… enable booster vaccination against diphtheria, tetanus and pertussis in … reactogenicity
and immunogenicity of reduced antigen content vaccine (dTpa) with a dose of diphtheria–tetanus–…

… reactogenic profile of licensed DTPa vaccines it is logical to assess the ability of the `low-dose'
booster with reduced antigen contents … compare the reactogenicity and immunogenicity of …

… Modern acellular reduced-antigen-content vaccines … immunogenicity and reactogenicity of
Boostrix™, GlaxoSmithKline Biologicals’ reduced-antigen-content diphtheria-tetanus acellular …

… being the increase in reactogenicity with each successive dose. The aim of this study was
to assess the immunogenicity, safety and reactogenicity of a reduced antigen, combined dTpa …

… that a reduced antigen content dTpa vaccine successfully induced a booster response to
vaccine antigens … with a reduced antigen content vaccine in children previously vaccinated with …

… safety and immunogenicity of either monovalent or combined acellular pertussis vaccines
in … safety and immunogenicity of a single dose of a diphtheria–tetanus–acellular pertussis …

… The reduced antigen content is designed to avoid the increasing reactogenicity historically
… This article reviews the immunogenicity, protective efficacy and reactogenicity of Tdap …

… Following vaccination with Tdap, subjects reported more pain, but less … fifth diphtheria–tetanus–acellular
pertussis (DTaP) dose at pre-school age. Here we report the immunogenicity of …

… The objective of this study was to assess immunogenicity, reactogenicity and safety of a …
diphtheria and tetanus and >96.0% of participants were seropositive for anti-pertussis antibodies…

… the reactogenicity of a new combined diphtheria, tetanus, tricomponent acellular pertussis
… This suggests that parents did not perceive this vaccine as reactogenic in the vast majority …